FAKTOR OPTIONSSCHEIN - INCYTE CO. Share Price

DE000GQ973S5

Market Closed - BOERSE MUENCHEN 11:56:04 17/05/2024 pm IST
4.01 ^EUR	-2.67%

Current month	-46.68%
1 month	-39.06%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart INCYTE CORPORATION

Latest news about INCYTE CORPORATION

Transcript : Incyte Corporation Presents at Bank of America Health Care Conference 2024, May-15-2024 08:00 AM	15/05
Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress	15/05	BU
Equities Close Mixed as Markets Weigh Consumer Inflation Survey	14/05	MT
Equities Close Mixed as Markets Parse Consumer Inflation Survey	14/05	MT

More news

Quotes 5-day view

Date	Price	Change
17/24/17	4.01	-2.67%
16/24/16	4.12	+3.52%
15/24/15	3.98	-1.24%
14/24/14	4.03	+0.50%
13/24/13	4.01	-37.34%

Real-time BOERSE MUENCHEN

Last update May 17, 2024 at 11:56 pm IST

More quotes

Static data

Product type	Exotische Produkte
Buy / Sell	CALL
Underlying	INCYTE CORPORATION
Issuer	Goldman Sachs
WKN	GQ973S
ISIN	DE000GQ973S5
Date issued	16/11/2023
Strike	68.23 $
Maturity	Unlimited
Parity	2.56 : 1
Emission price	8.49 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	10.57 €
Lowest since issue	2.435 €
Spread	0.03 €
Spread %	0.74%

Company Profile

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (85.6%); - royalties (14.2%); - income from research and cooperation agreements (0.2%).

Sector

More about the company

Ratings for Incyte Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Incyte Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

57.1 USD

Average target price

73.35 USD

Spread / Average Target

+28.46%

Consensus